Danh mục

Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness

Số trang: 14      Loại file: pdf      Dung lượng: 1.28 MB      Lượt xem: 9      Lượt tải: 0    
Hoai.2512

Xem trước 2 trang đầu tiên của tài liệu này:

Thông tin tài liệu:

Treatment with tumor-Infiltrating Lymphocytes (TIL) is an innovative therapy for advanced melanoma with promising clinical phase I/II study results and likely beneficial cost-effectiveness. As a randomized controlled trial on the effectiveness of TIL therapy in advanced melanoma compared to ipilimumab is still ongoing, adoption of TIL therapy by the field is confronted with uncertainty.
Nội dung trích xuất từ tài liệu:
Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness

Tài liệu được xem nhiều: